🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Tennessee › Memphis

Acute Myeloid Leukemia clinical trials in Memphis, TN

15 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi away
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi away
Ages 18 to 59 · All sexes · Updated Sep 28, 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi away
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi away
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi away
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi away
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

RecruitingPhase 2
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · All sexes · Updated Sep 17, 2026 · NCT05955261

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

RecruitingPhase 1
  • St. Jude Children's Research Hospital, Memphis
Up to age 25 · All sexes · Updated Sep 15, 2026 · NCT06810583

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecruitingPhase 3
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · All sexes · Updated Aug 24, 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
  • Baptist Clinical Research Institute, Memphis
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

RecruitingPhase 1
  • Baptist Health Care Corporation, Memphis
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT06399640

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RecruitingPhase 1
  • St. Jude Children's Research Hospital, Memphis
Ages 1 to 30 · All sexes · Updated Aug 3, 2026 · NCT06177067

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • St. Jude Childrens Research Hospital, Memphis
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RecruitingPhase 1
  • St. Jude Children's Research Hospital, Memphis
Up to age 21 · All sexes · Updated Apr 22, 2026 · NCT05101551

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

RecruitingPhase 1
  • St. Jude Children's Research Hospital, Memphis
Up to age 21 · All sexes · Updated Jan 23, 2026 · NCT06326463

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Memphis

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.